|
|
|
|
|
|
|
||
ARTICLE |
CORRESPONDENCE Yang Xu: yangxu{at}ucsd.edu
 Top Abstract RESULTSDISCUSSIONMATERIALS AND METHODSReferences |
|---|
) with its heavy chain counterpart (Eµ) in mice. This replacement, denoted EµR, substantially increases the accessibility of both V and J loci to V(D)J recombinase in pro–B cells and induces Igk rearrangement in these cells. However, EµR does not support Igk rearrangement in pre–B cells. Similar to that in MiE–/– pre–B cells, the accessibility of V segments to V(D)J recombinase is considerably reduced in EµR pre–B cells when compared with wild-type pre–B cells. Therefore, Eµ and MiE play developmental stage-specific roles in maintaining the sequential rearrangement of IgH and Igk loci by promoting the accessibility of V, D, and J loci to the V(D)J recombinase.
, human constant region; LM, ligation mediated; MAR, matrix attachment region; mC, mouse constant region; MiE, MAR/Igk intronic enhancer; MSRE-QPCR, methylation-sensitive restriction enzyme real-time quantitative PCR; PGK, phosphoglycerol kinase; RS, recombining sequence; RSS, recombination signal sequence; SE, signal end. M.A. Inlay and T. Lin contributed equally to this work.
The Ig and TCR genes are assembled through the somatic recombination of V (Variable), D (Diversity), and J (Junction) gene segments during the early stages of lymphocyte development (1). B lymphocytes express one set of the heavy chain (IgH) and either the
or 
light chain loci (IgL). V(D)J recombination of the IgH and IgL chain genes occurs in a sequential manner. IgH rearrangement occurs primarily in pro–B cells, and IgL rearrangement occurs primarily in pre–B cells (1). The accessibility of each antigen receptor locus to the recombination machinery regulates its timing and efficiency of rearrangement (2–4). During the appropriate developmental stage, chromatin remodeling complexes modify the chromatin structure of the locus and convert it into a state accessible to the V(D)J recombinase (5–7). Such changes in accessibility are thought to be mediated by cis-elements residing within each locus (5).
Both IgH and Igk loci contain an enhancer between the J segments and the constant region, which are called IgH intronic enhancer (Eµ) and matrix attachment region (MAR)/Igk intronic enhancer (MiE), respectively (8–12). Both loci also contain multiple other regulatory elements downstream or within their constant region exons. The Igk locus contains the 3'E (13) and Ed (14) enhancers, and the IgH locus contains four enhancer elements in its 3'EH regulatory region (hs3a, hs1/2, hs3b, and hs4; references 15–17). The deletion of Eµ in mice severely decreases VH to DJH rearrangement (18–20). The deletion of either MiE or 3'E from the endogenous Igk locus differentially decreases the rearrangement of Igk (21, 22). In addition, the deletion of both Igk enhancers abolishes Igk rearrangement, indicating that these two enhancers play redundant and essential roles in activating Igk rearrangement (23).
The mechanisms by which cis-elements activate Igk recombination remain unclear. One potential mechanism is through the activation of germline transcription from germline promoters located upstream of J (24–27), as 0 germline transcription (0GT [germline transcript]) appears to play a quantitative role in activating Igk rearrangement (28, 29). Germline transcription of V gene segments (VGT) may also play a role in regulating the accessibility of the V regions (30). Another mechanism could be DNA demethylation (31). In this context, DNA methylation is inversely correlated with the efficiency of Igk rearrangement, and Igk enhancers are critical for demethylation of the Igk locus (23). However, only a minor demethylation of Igk can be detected in WT pre–B cells (32), suggesting that demethylation occurs within a small pre–B cell population immediately before the rearrangement of this locus. Hypomethylation of the Igk locus resulting from the targeted deletion of the methyltransferase gene Dnmt1 is not sufficient to activate Igk rearrangement in pre–B cell lines, suggesting that DNA demethylation alone is not sufficient in activating Igk rearrangement (33).
Recent studies suggest that histone modification is involved in regulating the accessibility to V(D)J recombinase. Acetylation of the H3 and H4 histones spanning the DH–JH regions occurs during DH to JH rearrangement, and acetylation of VH histones occurs during VH to DJH rearrangement (34). However, VH histones are deactylated during the transition to the pre–B cell stage, in part as a result of a loss of IL-7 signaling (35). H3 and H4 acetylation at the Igk locus appears to originate at the pro–B cell stage (36, 37) but increases substantially in pre–B cells (37). Enhancer elements may contribute to the chromatin remodeling events by recruiting histone modifiers to the Ig loci (38). Overexpression of E2A is sufficient to activate Igk rearrangement likely through its direct binding to the Igk intronic enhancer (39, 40) and V promoters (41). In addition, E2A has been shown to interact with multiple histone acetyltransferase complexes (42–44).
Because enhancers are important in activating V(D)J rearrangement, we hypothesized that Eµ might be involved in this developmental stage-specific process. To test this hypothesis, we replaced the endogenous MiE with Eµ in mice.
 |
RESULTS |
|---|
|
TopAbstractRESULTSDISCUSSIONMATERIALS AND METHODSReferences |
|---|
|
+ B cell development
50% decrease in the total number of B cells compared with WT controls (Fig. 2 C
). The percentage of + splenic B cells was reduced, lowering the / ratio from 20:1 in WT mice to 6:1 in EµR mice (Fig. 2, B and D). These data indicate an impairment in the development of + B cells. This defect is not caused by impaired Igk expression because both the surface expression and transcription of Igk were identical between WT and EµR splenic + B cells (Fig. 2, E and F).
|
–/– mice (Fig. S1, A, B, and E; available at http://www.jem.org/cgi/content/full/jem.20052310/DC1). However, MiE–/– mice have a much more severe decrease in the / ratio in splenic B cells than that observed in EµR mice (Fig. S1, B and F).
|
constant region (mC) replaced with the human constant region (hC; Fig. S2 A, available at http://www.jem.org/cgi/content/full/jem.20052310/DC1). Analysis of +/hC and EµR/hC mice showed that they had similar populations of B cells in BM (Fig. S2 B). In the spleen, +/hC mice had approximately equal numbers of hC+ and mC+ B cells (Fig. S2, C and D). However, EµR/hC mice had a dramatic reduction in the percentage of mC+ B cells with a ratio of hC+/mC+ B cells of 6:1 (Fig. S2, C and D). Therefore, the overall efficiency of the EµR allele appears to be lower than that of the WT allele.
Igk rearrangement is activated by EµR in pro–B cells
To examine whether EµR affects the timing of V(D)J recombination, we used a PCR assay to analyze Igk rearrangement in WT and EµR homozygous pro– and pre–B cells (Fig. 4 A
). The degenerate V primer (VD), which binds to 90% of V gene segments, was used together with a primer downstream of J5 (primer MAR35; reference 26). Consistent with previous studies, a very low level of Igk rearrangement was detected in WT pro–B cells (Fig. 4 B, left; references 45, 46). However, rearrangement of the EµR allele is dramatically increased (16-fold) in the pro–B cells of EµR mice (Fig. 4, B and C). At the pre–B cell stage, the levels of Igk rearrangement were similar between the WT and EµR mice (Fig. 4 B, right).
|
1 gene segment and its recombination signal sequence (RSS) to analyze the level of unrearranged Igk allele in pro–B cells (Fig. 4 D, top). As this PCR reaction cannot amplify the majority of rearranged Igk alleles in pre–B cells, it allowed us to estimate the proportion of unrearranged Igk loci using genomic DNA from the nonrearranging ES cells as a control. Based on this assay, it was estimated that 90 and 50% of Igk alleles were unrearranged in WT and EµR pro–B cells, respectively, indicating substantial Igk rearrangement in EµR pro–B cells (Fig. 4 D). In addition, it was estimated that 50% of WT Igk alleles were unrearranged in pre–B cells, whereas 30% of EµR alleles were unrearranged (Fig. 4 D).
To further compare Igk rearrangement efficiency between the WT and EµR alleles, we analyzed Igk rearrangement in pro–, pre–, and mature + B cells derived from heterozygous (+/EµR) mice using primers VD and K2 (Fig. 4 E). The small size difference between the PCR products amplified from the rearranged WT and EµR Igk alleles allowed the direct comparison of the two alleles in the same reaction (Fig. 4 A). Consistent with the notion that rearrangement of the EµR allele is activated in pro–B cells, the levels of VJ1–5 rearrangement of the EµR allele were considerably increased when compared with those of the WT allele in +/EµR pro–B cells (Fig. 4 E, left lane). However, in +/EµR pre–B cells, VJ1–5 rearrangements of the WT allele were increased compared with those of the EµR allele (Fig. 4 E, middle lane), and, in splenic + B cells, VJ1–5 rearrangements of the WT allele appeared to surpass those of the EµR allele (Fig. 4 E, right lane). This trend of increasing contribution of the WT allele and decreasing contribution of the EµR allele at later stages of development suggests that the overall rearrangement of the EµR allele is less efficient than WT in pre–B cells and beyond.
EµR does not support Igk rearrangement in pre–B cells
Productive rearrangement of the Igk allele in EµR pro–B cells would lead to IgM surface expression and direct transition to the immature B cell stage, whereas EµR pro–B cells with nonproductive Igk rearrangements would differentiate into pre–B cells. If this hypothesis is true, the rearrangements detected in EµR pre–B cells could be nonproductive ones that originated at the pro–B cell stage. To identify the origin of the EµR rearrangements detected in pre–B cells, we took advantage of the finding that terminal deoxynucleotidyl transferase is expressed exclusively in pro–B cells and mediates the nontemplated insertion of nucleotides, called N nucleotides, into the junctions of V, D, and J gene segments (47, 48). Because terminal deoxynucleotidyl transferase is not expressed in pre–B cells, N-nucleotide insertions rarely occur in VJ junctions of WT B cells and can be regarded as a hallmark of V(D)J rearrangements that occurred at the pro–B cell stage. We amplified and sequenced VJ1 junctions from EµR pro–, pre–, and mature B cells as well as from WT pre–B cells (Fig. 5 A
). This analysis showed that 78% of VJ1 junctions in EµR pro–B cells contained N nucleotides. Similarly, 67% of VJ1 junctions in EµR pre–B cells contained N nucleotides in contrast to the 10% of VJ1 junctions in WT pre–B cells that contained N nucleotides. In addition, VJ1 rearrangements observed in EµR pre–B cells were almost entirely nonproductive (21 of 24 sequences out of frame), suggesting that these rearrangements represent nonproductive rearrangements carried over from the pro–B cell stage. In further support of this notion, >80% of VJ5 junctions (14 of 17 sequences) contain N nucleotides and are mostly out of frame in EµR pre–B cells (unpublished data).
|
1 gene segment in WT and EµR pre–B cells as described previously (49). Compared with that in WT pre–B cells, the level of J1 SE breaks was reduced by approximately fourfold in EµR pre–B cells (Fig. 5 B). Considering that the level of unrearranged Igk alleles in EµR pre–B cells was 60% of that in WT pre–B cells (Fig. 4 D), this suggested that the rearrangement frequency of the EµR allele was only 40% of that of the WT Igk allele in pre–B cells. Because a similar defect in Igk rearrangement was observed in MiE-deleted mice, these findings indicate that Eµ cannot functionally replace MiE to support V(D)J rearrangement in pre–B cells.
Despite the high frequency of N-nucleotide insertions in VJ1 in EµR pro– and pre–B cells, only 37% of VJ1 rearrangements from splenic + B cells contained N nucleotides (Fig. 5 A), suggesting that pro–B cell–derived rearrangements may be negatively selected during development and, additionally, that some rearrangement can occur beyond the pro–B and pre–B cell stages in EµR B cells. Recent studies suggest that 25–50% of mature B cells may have undergone receptor editing (50–52), a process by which recombination in light chain genes is reactivated to remove autoreactive antibodies (53–55). Therefore, it is likely that EµR B cells also undergo robust receptor editing. We analyzed V usage in B cells at various developmental stages in EµR mice and WT mice and found that V2 family members were used frequently in VJ1 rearrangements in EµR pro– and pre–B cells (50 and 37%, respectively) but less frequently in splenic B cells (12%). This is consistent with a change in the B cell repertoire between BM and peripheral B cells (Fig. 5 C).
Recombining sequence (RS) rearrangement between an RSS within the JC intron (iRS) and the RS sequence 21 kb downstream of C is a primary mechanism for the receptor editing of Igk (56). To directly test whether EµR B cells actively undergo receptor editing of Igk, we analyzed the frequency of RS recombination in EµR and WT pro– and pre–B cells using a semiquantitative PCR assay as previously described (Fig. 5 D; reference 56). Although little RS rearrangement was detected in WT and EµR pro–B cells, RS recombination was increased in EµR pre–B cells when compared with that in WT pre–B cells, which is consistent with the findings that the J region is accessible in EµR pre–B cells (Fig. 5 E).
The J region becomes accessible in EµR pro–B cells and remains so in pre–B cells
To understand the mechanisms by which EµR activates Igk rearrangement at the pro–B cell stage, we analyzed germline transcription in pro– and pre–B cells sorted from WT and EµR BM. A real-time quantitative PCR strategy was designed to determine the amount of GT initiating from promoters upstream of the J gene segments (0GT) using primers immediately upstream of J1 and within the C exon. mRNA levels of ß-actin were also analyzed by quantitative PCR and used as the control for the input RNA amount. Consistent with increased accessibility of Igk loci in EµR pro–B cells, our analysis indicated an approximate threefold increase in the amount of 0 transcripts in EµR pro–B cells when compared with WT pro–B cells (Fig. 6 A
). The amount of 0 transcript in EµR pre–B cells was similar to that in WT pre–B cells, suggesting that the Igk locus remains in an open configuration at the J region in EµR pre–B cells (Fig. 6 A).
|
and C exons (JC intron) in EµR and WT pro– and pre–B cells. The methylation status at an HhaI site residing within the JC intron just downstream of the J5 gene segment has been frequently analyzed as an indicator of the methylation status of the JC region (Fig. 6 B; references 32, 37, 58). We designed a quantitative real-time PCR assay to detect the amount of DNA that was not cut at the HhaI site (methylated) using primers that flank that site (q1f and q1r) and compared it with undigested controls (Fig. 6 B). Consistent with previous findings, our analysis indicated little demethylation in the pro– or pre–B cells of WT mice (Fig. 6 C; reference 32). In contrast, JC demethylation was substantially increased in the pro–B cells of EµR mice (Fig. 6 C). More strikingly, the majority of Igk loci appeared to be demethylated in the EµR pre–B cells (Fig. 6 C). Therefore, this assay demonstrates that Eµ has the ability to induce demethylation of the JC region in pro– and pre–B cells.
To confirm that the notable differences in methylation observed at the HhaI site are representative of the entire JC region, we analyzed the methylation status of adjacent CpG sites using bisulfite genomic sequencing (59). Consistent with the methylation-sensitive restriction enzyme real-time quantitative PCR (MSRE-QPCR) assay, in WT pro– and pre–B cells, Igk loci were hypermethylated at nearly all CpG sites examined (Fig. 6, B and E). In EµR pro–B cells, Igk loci were partially demethylated with a mean of 25% (Fig. 6, E and F). This pattern is distinct from the monoallelic demethylation pattern of Igk loci observed in WT splenic B cells, where normally one allele is fully methylated and the other allele is fully demethylated (23, 32). In EµR pre–B cells, the JC region was highly demethylated with a mean of 14.3 of 17 sites (86%) unmethylated per sequence (Fig. 6, E and F).
We have previously observed the hypomethylation of Igk loci in mature splenic MiE–/– B cells, suggesting the possibility that the hypomethylation observed in EµR loci is caused by the absence of MiE (23). However, similar to the WT allele, the MiE-deleted Igk locus is mostly methylated in pre–B cells (Fig. S3, available at http://www.jem.org/cgi/content/full/jem.20052310/DC1). Thus, the hypomethylation of the EµR locus is caused by the presence of Eµ, not the absence of MiE. In conclusion, our findings indicate that Eµ can promote robust chromatin remodeling of the JC region in both pro– and pre–B cells.
The V regions are accessible in EµR pro–B cells, but not in pre–B cells
V(D)J recombination requires that both the V region and (D)J region are accessible to the recombination machinery. Because V germline transcription (VGT) predicts their accessibility to V(D)J recombinase (1), we examined germline transcription of five V gene segments that spread throughout the locus in EµR pro– and pre–B cells (Fig. 7 A
). The amount of VGT was quantitated by real-time PCR using primers annealing to the transcribed regions downstream of the V RSS, which are deleted upon rearrangement and, thus, only amplify transcription from unrearranged V promoters (Fig. 7 B). In pooled EµR pro–B cells, the V germline transcription of three of five V genes was increased in EµR pro–B cells when compared with WT pro–B cells (Fig. 7 C). Thus, consistent with the increased rearrangement of the EµR allele in pro–B cells, EµR appears to increase the accessibility of V genes in pro–B cells.
|
segments in EµR pre–B cells. Because the percentage of V in germline configuration is likely to be different between WT and EµR pre–B cells, the ratio of the amount of each germline V in EµR pre–B cells versus WT pre–B cells was analyzed by quantitative real-time PCR using primers that are specific to each unrearranged V (Fig. 7 E). By normalizing the levels of VGT to the amount of germline V, germline transcription of four of the five V genes examined was markedly reduced in EµR pre–B cells when compared with that in WT pre–B cells, suggesting a reduced V accessibility in EµR pre–B cells (Fig. 7 D).
Histone acetylation is another hallmark for accessibility to the V(D)J recombinase (38). Therefore, we also examined histone acetylation of V segments in pooled WT and EµR pre–B cells by chromatin immunoprecipitation (ChIP) assays using an antibody against acetylated histone H3. To specifically detect only germline V gene segments, we used the same primer sets that were used to analyze VGT to determine the amount of germline V in both immunoprecipitated chromatin and total input chromatin. In pooled pre–B cells sorted from five EµR and five age-matched WT littermates, histone acetylation of the analyzed V gene segments was generally reduced (Fig. 7 F). As a control, we also examined acetylation at the C exon and found equivalent levels of acetylation between EµR and WT pre–B cells, which is consistent with the observation that the JC region remains open in pre–B cells (Fig. 7 F). Together with the reduction in VGT, these data indicate that the inefficient Igk rearrangement observed in EµR pre–B cells is caused by the reduced accessibility of V regions to the V(D)J recombinase.
The reduction in V accessibility observed in EµR pre–B cells could be caused by the presence of Eµ and/or the absence of MiE. To distinguish between these possibilities, we analyzed V germline transcription in pre–B cells sorted from MiE–/– mice. Germline transcription of most V genes analyzed was considerably reduced in MiE–/– pre–B cells compared with that in WT pre–B cells, indicating that MiE is required for the accessibility of V in pre–B cells (Fig. 7 G). In contrast to that in EµR pre–B cells, 0GT was dramatically reduced in MiE–/– pre–B cells (Fig. 7 G). VGT was normal in 3'E–/– pre–B cells, but, consistent with previous studies (22, 23), 0GT was reduced (Fig. 7 H). Therefore, MiE plays an important role in promoting the accessibility of both V and J regions in pre–B cells, and Eµ can compensate for MiE in opening up the J region but not the V region in EµR pre–B cells.
|
DISCUSSION |
|---|
|
TopAbstractRESULTSDISCUSSIONMATERIALS AND METHODSReferences |
|---|
and J regions as well as DNA demethylation at the J region are substantially increased in EµR pro–B cells, indicating that Eµ is sufficient to promote the accessibility of these loci to V(D)J recombinase and activate V(D)J recombination in pro–B cells.
To maintain the sequential rearrangement of IgH and IgL chain genes, the rearrangement of IgH loci occurs in pro–B cells but not in pre–B cells. Analysis of B cell development and Igk rearrangement suggests that Igk rearrangement is not efficient in EµR pre–B cells. In further support of this notion, the percentage of VJ junctions containing N nucleotides is similar in EµR pro–B and pre–B cells, indicating that the majority of the Igk rearrangements detected in EµR pre–B cells have occurred in pro–B cells. In addition, the level of RAG-induced SE breaks is markedly reduced in EµR pre–B cells. Therefore, Eµ promotes V(D)J recombination in pro–B cells but cannot support efficient V(D)J rearrangement in pre–B cells, further implicating its importance in maintaining the sequential rearrangement of IgH and IgL chain genes.
Efficient V(D)J recombination requires that both V and J regions are accessible to the V(D)J recombinase. Because the germline transcription and histone acetylation through J is normal in EµR pre–B cells, the inefficient rearrangement of the EµR allele in pre–B cells is not caused by the inaccessibility of the J region to the V(D)J recombinase. In contrast, germline transcription and histone acetylation of unrearranged V gene segments are noticeably reduced in EµR pre–B cells, indicating that accessibility of the V region is reduced in EµR pre–B cells. This scenario is remarkably similar to the IgH locus in normal pre–B cells, where the VH region becomes inaccessible but the DJH region remains accessible (35). As germline transcription of V and J is considerably reduced in MiE–/– pre–B cells, the reduced accessibility of V in EµR pre–B cells is caused by the lack of MiE. Therefore, Eµ and MiE maintain the sequential rearrangement of the Ig loci by playing developmental stage-specific roles in promoting the chromatin remodeling at V regions.
Because Ig enhancers are essentially clusters of protein-binding sites, the function of an enhancer is dictated by the array of DNA-binding factors it recruits. A comparison of the known functional motifs within Eµ and MiE shows that µA and µB sites are only present in Eµ. The binding of PU.1 and ETS family proteins to µA and µB sites promotes chromatin accessibility to endonucleases (60). In addition, although two E2A-binding E boxes, which are important for activating Igk rearrangement, are present in MiE (40), three E2A-binding E boxes are present in Eµ (61). The unique combination of functional motifs within Eµ might account for its activities in activating V(D)J recombination in pro–B cells.
It remains unclear why Eµ cannot compensate for MiE function in promoting the accessibility of V regions in pre–B cells. Most of the known protein-binding sites within MiE are also found in Eµ. One exception is the NF-B–binding site. However, deletion of this site has no considerable impact on Igk rearrangement (40). Both MiE and Eµ contain MARs that could bind to the nuclear matrix and extend the range of the action of its associated enhancers (62–65). It is possible that the MARs of Eµ and MiE function differently in promoting V accessibility in pre–B cells. Although neither the two MARs of Eµ nor the MAR of MiE is required for rearrangement (66, 67), increased premature Igk rearrangement in pro–B cells has been detected in mice with a deletion of MAR of MiE (67, 68). It is possible that certain unidentified elements within MiE are required for promoting the accessibility of V in pre–B cells. Alternatively, some elements within Eµ, such as µNR, might dominantly suppress its activity in promoting accessibility in V regions in pre–B cells (69).
Recent studies indicate that during recombination, Ig loci migrate to the nuclear center (70), where they contract (71) via DNA-looping (72, 73) mechanisms that bring distal V segments in close proximity to the enhancers (74). The ability of Eµ and MiE to regulate V-region accessibility as far as 3 Mb away suggests that these enhancers may also play a role in regulating higher order chromatin modifications. Further analysis of the chromatin remodeling in EµR and MiE–/– precursor B cells will help to define the functions of intronic enhancers in regulating such processes. In summary, the IgH and Igk intronic enhancers activate the sequential rearrangement of Ig loci by inducing stage-specific chromatin remodeling events in regions proximal to the enhancers and coordinate with V promoters to induce accessibility at distal V regions.
|
MATERIALS AND METHODS |
|---|
|
TopAbstractRESULTSDISCUSSIONMATERIALS AND METHODSReferences |
|---|
into the targeting construct (40). The targeting construct was linearized with PvuI and was electroporated into ES cells as described previously (75). Transfected ES cells were cultured with 300 µg/ml G418 and 1 µM gancyclovir to select for integration by homologous recombination. Positive clones were first screened by PCR and then by Southern blotting, digesting with EcoRI and probing with probe A as previously described (40). The WT locus produces a 15.1-kb fragment, whereas the targeted locus produces a 12.2-kb fragment. The floxed PGK-neor was removed through Cre/loxP-mediated deletion as described previously (21) and was screened by PCR and Southern blotting under the same conditions. The final configuration, called EµR, produces an 11.0-kb fragment. Positive clones were then subcloned and rescreened to ensure purity. EµR ES cells were injected into mouse blastocysts to produce chimeric mice, which were bred and screened for germline transmission of the EµR allele.
Cell purification and flow cytometry.
BM and spleen cells were harvested in FACS buffer (3% FCS in PBS) and purified into single-cell suspensions. For total white blood cell counts, splenocytes were counted in 2% glacial acetic acid. For purification and flow cytometry, red blood cells were removed by treatment with red blood cell lysis buffer (0.15 M NH4Cl, 1 mM KHCO3, and 0.1 mM Na2EDTA, pH 7.0) for 5 min at room temperature. 1 million cells were pretreated with 1 µg FcBlock (BD Biosciences) and stained in 100-µl reactions on ice for 15 min. If necessary, cells were washed and stained with streptavidin-coated dyes under the same conditions. Cells were resuspended in 0.5 µg/ml propidium iodide in FACS buffer to stain for dead cells. For spleen cell stains, live cells within the lymphocyte gate were analyzed. Additionally, to exclude clumped cells, only small lymphocytes were analyzed. For BM stains, live lymphocytes and granulocytes were analyzed. Antibodies used are as follows: anti–B220-PE (BD Biosciences), anti–IgM-FITC (BD Biosciences), anti–CD43-biotin (BD Biosciences), anti–mouse Ig-FITC (BD Biosciences), anti–mouse Ig-biotin (BD Biosciences), anti–CD3-FITC (BD Biosciences), streptavidin-APC (eBioscience), and streptavidin-PECy5 (eBioscience). To obtain purified pro– and pre–B cells, BM was stained with B220-PE, IgM-FITC, and CD43-biotin and was washed and restained with streptavidin-PECy5. Pro–B cells (B220+, IgM–, and CD43+) and pre–B cells (B220+, IgM–, and CD43–) were sorted using a FACSVantage Cell Sorter (Becton Dickinson). + spleen cells were sorted by negative selection using the MACS system (Miltenyi Biotec), anti–Ig-biotin antibodies, and anti-CD43 and anti-biotin microbeads according to the manufacturer's instructions and as previously described (40). The purity of sorted B cells was confirmed by FACS analysis. All purifications used were >95% B220+.
Primer sequences.
Sequences of all primers used are listed in the supplemental material (available at http://www.jem.org/cgi/content/full/jem.20052310/DC1).
Real-time quantitative RT-PCR analysis.
RNA from sorted pro–, pre–, and + splenic B cells was purified using the RNAeasy Purification Kit (QIAGEN) as described previously (40). RNA was converted to cDNA using the Superscript first strand cDNA synthesis kit (Invitrogen) as described previously (40). cDNA was amplified using the 2x SYBR Green Master Mix (Applied Biosystems) in a sequence detection system (Prism 7000; ABI Biosystems). PCR results were analyzed using Prism 7000 SDS software (ABI Biosystems) and relative transcription calculated using the 
Ct method according to the manufacturer's instructions.
Rearrangement PCR assay.
DNA was purified from sorted B cell populations as described previously (23). Rearranged Igk alleles were amplified using the degenerate V primer (VD) and either primer K6 or primer MAR35 under PCR conditions that were previously described (23, 40). PCR products were run on an agarose gel, transferred to a membrane, and probed as previously described (23). Heavy chain rearrangement was amplified by PCR and analyzed by Southern blotting as previously described (40). RS rearrangement was analyzed with a PCR assay with primers iRS and a primer downstream of the RS RSS (primer R2) as previously described (56). The intensity of each band was calculated using a phosphorimager (Storm; GE Healthcare) as previously described (23).
Cloning and sequencing of VJ1 rearrangements.
Rearranged Igk alleles were amplified using KOD Hotstart Polymerase (Calbiochem) according to the manufacturer's instructions. A degenerate V primer with a BamHI restriction sequence inserted (VD.bam) and a primer that anneals between J1 and J2 with an EcoRI restriction sequence added (J1.eco) were used. PCR products were purified using the Wizard SV PCR and Gel Clean-Up System (Promega) according to the manufacturer's instructions, digested with BamHI and EcoRI, and cloned into pBluescript. Clones were sequenced by Eton Biosciences using the T3 primer. Sequences were analyzed by IgBLAST software, which is available from the National Center for Biotechnology Information's website (http://www.ncbi.nlm.nih.gov/igblast/) to determine the V gene segment used and to identify junctional insertions and deletions. N-nucleotide insertions were determined using previously described methods (48). In brief, insertions with sequences complementary to V or J ends were classified as P nucleotides. Insertions that could not be classified as P nucleotides were considered N nucleotides. For example, in the hypothetical sequence ACCGGCTGG, where the underlined sequences correspond to V (left) and J1 (right), GGC would represent inserted nucleotides. Because the inserted GG nucleotides are complementary to the V end, they would be classified as P nucleotides. The inserted C nucleotide, which is not complementary to either V or J ends, would be classified as an N nucleotide.
Detection of SE breaks by quantitative LM-PCR.
Genomic DNA was purified from sorted pre–B cell populations as described previously (49). LM-PCR was performed essentially as described previously with all of the reagents provided by J. Curry of M. Schlissel's laboratory (University of California, Berkeley, Berkeley, CA; reference 49). In brief, 500 ng of genomic DNA was used in each ligation reaction. Quantitative real-time PCR analysis of the levels of the ligation product of J1 SE break was performed exactly as described previously (49). The amount of input genomic DNA was determined by quantitative real-time PCR with primers specific for the ß-actin promoter.
MSRE-QPCR.
DNA from sorted B cells was digested in a 50-µl reaction volume with 20 U EcoRI (New England Biolabs, Inc.) for 1 h at 37°C. Subsequently, 23 µl were transferred to a separate tube, and 20 U of both BamHI and HhaI were added. The original EcoRI digest and the EcoRI, BamHI, and HhaI triple digests were incubated overnight at 37°C. Restriction enzymes were inactivated by heating at 65°C for 20 min. Approximately 0.5 µl of digest product were used per well for real-time quantitative PCR.
Bisulfite genomic sequencing.
DNA from sorted B cells was converted with sodium bisulfite using the EZ DNA Methylation Kit (Zymo Research) according to the manufacturer's instructions. Converted DNA was amplified in two rounds of PCR. In the first round, bis1.1 and either bis2.1 or bis3.1 primers were used in the following touchdown PCR program: a 5-min 95°C initial incubation followed by 15 cycles of 94°C for 1 min, x°C for 1 min, and 72°C for 2 min and 30 s, where x is 64°C for the first cycle and lowers 1°C per cycle. This was followed by 15 cycles of 94°C for 30 s, 50°C for 30 s, 72°C for 2 min and 30 s, and a final extension for 10 min at 72°C. 5–10% of the PCR product was used in a second round of PCR using primer bis1.2eco and either bis2.2bam or bis3.2bam and using KOD Hotstart Polymerase (Calbiochem) according to the manufacturer's protocol. The PCR program for the second round was 95°C for 2 min followed by 32 cycles of 94°C for 20 s, 55°C for 30 s, and 68°C for 2 min and 30 s. This was followed by a final extension for 10 min at 68°C. PCR products were purified using the Wizard SV Gel and PCR Clean-Up System (Promega), digested with BamHI and EcoRI, gel purified, and cloned into pBluescript. Sequencing was provided by the Cancer Center sequencing facility of the University of California, San Diego (UCSD).
ChIP.
Sorted pre–B cells were pooled and fixed in 1% formaldehyde. Subsequent steps followed a previously described protocol (76) with some modifications. Fixed cells were lysed in L1 lysis buffer (50 mM Tris, pH 8.0, 2 mM EDTA, 0.1% NP-40, and 10% glycerol) supplemented with protease inhibitors. Nuclei were pelleted and resuspended in 300 µl L2 lysis buffer (50 mM Tris, pH 8.0, 0.1% SDS, and 5 mM EDTA) with protease inhibitors. Chromatin was fragmented by sonication, centrifuged, and diluted in dilution buffer (50 mM Tris, pH 8.0, 5 mM EDTA, 0.2 M NaCl, and 0.5% NP-40). After preclearing, immunoprecipitation was performed overnight at 4°C using 3 µl antiacetylated histone H3 antibody (Upstate Biotechnology). Immune complexes were collected with ssProtein A/G for 30 min and washed three times in washing buffer (20 mM Tris, pH 8.0, 0.1% SDS, 0.5 M NaCl, 2 mM EDTA, and 1% NP-40) and once in 0.5 M LiCl followed by three washes with TE buffer (10 mM Tris and 1 mM EDTA). Immune complexes were extracted three times with 100 µl of extraction buffer (TE buffer containing 2% SDS). DNA–protein cross-linking was reversed by heating at 65°C for 8 h. After proteinase K (100 µg for 2 h) digestion, DNA was extracted with phenol/chloroform and precipitated in ethanol. The UCSD Animal Subjects Committee approved all experiments that involved mice.
Online supplemental material.
Fig. S1 shows the analysis of B cell populations in MiE–/– BM and spleen by flow cytometry. Fig. S2 shows the analysis of B cell populations in EµR x hC BM and spleen. Fig. S3 shows the analysis of methylation in MiE+/– pre–B cells. Supplemental material also provides a list of all primer sequences used. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20052310/DC1.
|
Acknowledgments |
|---|
This work was supported by a National Institutes of Health grant (AI44838) to Y. Xu.
The authors have no conflicting financial interests.
Submitted: 17 November 2005
Accepted: 19 May 2006
|
References |
|---|
|
TopAbstractRESULTSDISCUSSIONMATERIALS AND METHODSReferences |
|---|
1 Bassing, C.H., W. Swat, and F.W. Alt. 2002. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 109:S45–S55.[CrossRef][Medline]
2 Yancopoulos, G.D., and F.W. Alt. 1985. Developmentally controlled and tissue-specific expression of unrearranged Vh gene segments. Cell. 40:271–281.[CrossRef][Medline]
3 Alt, F.W., T.K. Blackwell, and G.D. Yancopoulos. 1987. Development of the primary antibody repertoire. Science. 238:1079–1087.
4 Stanhope-Baker, P., K.M. Hudson, A.L. Shaffer, A. Constantinescu, and M.S. Schlissel. 1996. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell. 85:887–897.[CrossRef][Medline]
5 Sleckman, B.P., J.R. Gorman, and F.W. Alt. 1996. Accessibility control of antigen-receptor variable-region gene assembly: role of cis-acting elements. Annu. Rev. Immunol. 14:459–481.[CrossRef][Medline]
6 Hesslein, D.G., and D.G. Schatz. 2001. Factors and forces controlling V(D)J recombination. Adv. Immunol. 78:169–232.[Medline]
7 Schlissel, M.S. 2003. Regulating antigen-receptor gene assembly. Nat. Rev. Immunol. 3:890–899.[CrossRef][Medline]
8 Parslow, T.G., and D.K. Granner. 1982. Chromatin changes accompany immunoglobulin kappa gene activation: a potential control region within the gene. Nature. 299:449–451.[CrossRef][Medline]
9 Emorine, L., M. Kuehl, L. Weir, P. Leder, and E.E. Max. 1983. A conserved sequence in the immunoglobulin J kappa-C kappa intron: possible enhancer element. Nature. 304:447–449.[CrossRef][Medline]
10 Queen, C., and D. Baltimore. 1983. Immunoglobulin gene transcription is activated by downstream sequence elements. Cell. 33:741–748.[CrossRef][Medline]
11 Gillies, S.D., S.L. Morrison, V.T. Oi, and S. Tonegawa. 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell. 33:717–728.[CrossRef][Medline]
12 Banerji, J., L. Olson, and W. Schaffner. 1983. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell. 33:729–740.[CrossRef][Medline]
13 Meyer, K.B., and M.S. Neuberger. 1989. The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J. 8:1959–1964.[Medline]
14 Liu, Z.-M., J.B. George-Raizen, S. Li, K.C. Meyers, M.Y. Chang, and W.T. Garrard. 2002. Chromatin structural analyses of the mouse Igkappa gene locus reveal new hypersensitive sites specifying a transcriptional silencer and enhancer. J. Biol. Chem. 277:32640–32649.
15 Pettersson, S., G.P. Cook, M. Bruggemann, G.T. Williams, and M.S. Neuberger. 1990. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus. Nature. 344:165–168.[CrossRef][Medline]
16 Dariavach, P., G.T. Williams, K. Campbell, S. Pettersson, and M.S. Neuberger. 1991. The mouse IgH 3'-enhancer. Eur. J. Immunol. 21:1499–1504.[Medline]
17 Lieberson, R., S.L. Giannini, B.K. Birshtein, and L.A. Eckhardt. 1991. An enhancer at the 3' end of the mouse immunoglobulin heavy chain locus. Nucleic Acids Res. 19:933–937.
18 Chen, J., F. Young, A. Bottaro, V. Stewart, R.K. Smith, and F.W. Alt. 1993. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO J. 12:4635–4645.[Medline]
19 Serwe, M., and F. Sablitzky. 1993. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO J. 12:2321–2327.[Medline]
20 Perlot, T., F.W. Alt, C.H. Bassing, H. Suh, and E. Pinaud. 2005. Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc. Natl. Acad. Sci. USA. 102:14362–14367.
21 Xu, Y., L. Davidson, F.W. Alt, and D. Baltimore. 1996. Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. Immunity. 4:377–385.[CrossRef][Medline]
22 Gorman, J.R., N. van der Stoep, R. Monroe, M. Cogne, L. Davidson, and F.W. Alt. 1996. The Ig kappa 3' enhancer influences the ratio of Ig kappa versus Ig lambda B lymphocytes. Immunity 5:241–252.[CrossRef][Medline]
23 Inlay, M., F.W. Alt, D. Baltimore, and Y. Xu. 2002. Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. Nat. Immunol. 3:463–468.[CrossRef][Medline]
24 Perry, R.P., D.E. Kelley, C. Coleclough, J.G. Seidman, P. Leder, S. Tonegawa, G. Matthyssens, and M. Weigert. 1980. Transcription of mouse kappa chain genes: implications for allelic exclusion. Proc. Natl. Acad. Sci. USA. 77:1937–1941.
25 Van Ness, B.G., M. Weigert, C. Coleclough, E.L. Mather, D.E. Kelley, and R.P. Perry. 1981. Transcription of the unrearranged mouse C kappa locus: sequence of the initiation region and comparison of activity with a rearranged V kappa-C kappa gene. Cell. 27:593–602.[CrossRef][Medline]
26 Schlissel, M.S., and D. Baltimore. 1989. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene-transcription. Cell. 58:1001–1007.[CrossRef][Medline]
27 Liang, H.E., L.Y. Hsu, D. Cado, and M.S. Schlissel. 2004. Variegated transcriptional activation of the immunoglobulin kappa locus in pre-b cells contributes to the allelic exclusion of light-chain expression. Cell. 118:19–29.[CrossRef][Medline]
28 Ferradini, L., H. Gu, A. De Smet, K. Rajewsky, C.A. Reynaud, and J.C. Weill. 1996. Rearrangement-enhancing element upstream of the mouse immunoglobulin kappa chain J cluster. Science. 271:1416–1420.[Abstract]
29 Cocea, L., A. De Smet, M. Saghatchian, S. Fillatreau, L. Ferradini, S. Schurmans, J.C. Weill, and C.A. Reynaud. 1999. A targeted deletion of a region upstream from the J cluster impairs chain rearrangement in cis in mice and in the 103/bcl2 cell line. J. Exp. Med. 189:1443–1450.
30 Casellas, R., M. Jankovic, G. Meyer, A. Gazumyan, Y. Luo, R. Roeder, and M. Nussenzweig. 2002. OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin kappa genes. Cell. 110:575–585.[CrossRef][Medline]
31 Inlay, M., and Y. Xu. 2003. Epigenetic regulation of antigen receptor rearrangement. Clin. Immunol. 109:29–36.[CrossRef][Medline]
32 Mostoslavsky, R., N. Singh, A. Kirillov, R. Pelanda, H. Cedar, A. Chess, and Y. Bergman. 1998. Kappa chain monoallelic demethylation and the establishment of allelic exclusion. Genes Dev. 12:1801–1811.
33 Cherry, S.R., C. Beard, R. Jaenisch, and D. Baltimore. 2000. V(D)J recombination is not activated by demethylation of the kappa locus. Proc. Natl. Acad. Sci. USA. 97:8467–8472.
34 Chowdhury, D., and R. Sen. 2001. Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J. 20:6394–6403.[CrossRef][Medline]
35 Chowdhury, D., and R. Sen. 2003. Transient IL-7/IL-7R signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrangements. Immunity. 18:229–241.[CrossRef][Medline]
36 Maes, J., L.P. O'Neill, P. Cavelier, B.M. Turner, F. Rougeon, and M. Goodhardt. 2001. Chromatin remodeling at the Ig loci prior to V(D)J recombination. J. Immunol. 167:866–874.
37 Goldmit, M., Y. Ji, J. Skok, E. Roldan, S. Jung, H. Cedar, and Y. Bergman. 2005. Epigenetic ontogeny of the Igk locus during B cell development. Nat. Immunol. 6:198–203.[CrossRef][Medline]
38 McMurry, M.T., and M.S. Krangel. 2000. A role for histone acetylation in the developmental regulation of VDJ recombination. Science. 287:495–498.
39 Romanow, W.J., A.W. Langerak, P. Goebel, I.L. Wolvers-Tettero, J.J. van Dongen, A.J. Feeney, and C. Murre. 2000. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell. 5:343–353.[CrossRef][Medline]
40 Inlay, M.A., H. Tian, T. Lin, and Y. Xu. 2004. Important roles for E protein binding sites within the immunoglobulin chain intronic enhancer in activating V J rearrangement. J. Exp. Med. 200:1205–1211.
41 Goebel, P., N. Janney, J.R. Valenzuela, W.J. Romanow, C. Murre, and A.J. Feeney. 2001. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194:645–656.
42 Eckner, R., T.P. Yao, E. Oldread, and D.M. Livingston. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478–2490.
43 Qiu, Y., A. Sharma, and R. Stein. 1998. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol. Cell. Biol. 18:2957–2964.
44 Massari, M.E., P.A. Grant, M.G. Pray-Grant, S.L. Berger, J.L. Workman, and C. Murre. 1999. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell. 4:63–73.[CrossRef][Medline]
45 Ehlich, A., S. Schaal, H. Gu, D. Kitamura, W. Muller, and K. Rajewsky. 1993. Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development. Cell. 72:695–704.[CrossRef][Medline]
46 Novobrantseva, T.I., V.M. Martin, R. Pelanda, W. Muller, K. Rajewsky, and A. Ehlich. 1999. Rearrangement and expression of immunoglobulin light chain genes can precede heavy chain expression during normal B cell development in mice. J. Exp. Med. 189:75–88.
47 Gilfillan, S., A. Dierich, M. Lemeur, C. Benoist, and D. Mathis. 1993. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science. 261:1175–1178.
48 Komori, T., A. Okada, V. Stewart, and F.W. Alt. 1993. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science. 261:1171–1175.
49 Curry, J.D., L. Li, and M.S. Schlissel. 2005. Quantification of Jkappa signal end breaks in developing B cells by blunt-end linker ligation and qPCR. J. Immunol. Methods. 296:19–30.[CrossRef][Medline]
50 Casellas, R., T.A. Shih, M. Kleinewietfeld, J. Rakonjac, D. Nemazee, K. Rajewsky, and M.C. Nussenzweig. 2001. Contribution of receptor editing to the antibody repertoire. Science. 291:1541–1544.
51 Novobrantseva, T., S. Xu, J.E. Tan, M. Maruyama, S. Schwers, R. Pelanda, and K.P. Lam. 2005. Stochastic pairing of Ig heavy and light chains frequently generates B cell antigen receptors that are subject to editing in vivo. Int. Immunol. 17:343–350.
52 Verkoczy, L.K., A.S. Martensson, and D. Nemazee. 2004. The scope of receptor editing and its association with autoimmunity. Curr. Opin. Immunol. 16:808–814.[CrossRef][Medline]
53 Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999–1008.
54 Nussenzweig, M.C. 1998. Immune receptor editing: revise and select. Cell. 95:875–878.[CrossRef][Medline]
55 Nemazee, D., and M. Weigert. 2000. Revising B cell receptors. J. Exp. Med. 191:1813–1817.
56 Retter, M.W., and D. Nemazee. 1998. Receptor editing occurs frequently during normal B cell development. J. Exp. Med. 188:1231–1238.
57 Bergman, Y., A. Fisher, and H. Cedar. 2003. Epigenetic mechanisms that regulate antigen receptor gene expression. Curr. Opin. Immunol. 15:176–181.[CrossRef][Medline]
58 Goldmit, M., M. Schlissel, H. Cedar, and Y. Bergman. 2002. Differential accessibility at the {kappa} chain locus plays a role in allelic exclusion. EMBO J. 21:5255–5261.[CrossRef][Medline]
59 Frommer, M., L.E. McDonald, D.S. Millar, C.M. Collis, F. Watt, G.W. Grigg, P.L. Molloy, and C.L. Paul. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA. 89:1827–1831.
60 Nikolajczyk, B.S., J.A. Sanchez, and R. Sen. 1999. ETS protein-dependent accessibility changes at the immunoglobulin mu heavy chain enhancer. Immunity. 11:11–20.[Medline]
61 Ernst, P., and S.T. Smale. 1995. Combinatorial regulation of transcription II: the immunoglobulin mu heavy chain gene. Immunity. 2:427–438.[CrossRef][Medline]
62 Cockerill, P.N., and W.T. Garrard. 1986. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell. 44:273–282.[CrossRef][Medline]
63 Cockerill, P.N., M.H. Yuen, and W.T. Garrard. 1987. The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements. J. Biol. Chem. 262:5394–5397.
64 Jenuwein, T., W.C. Forrester, L.A. Fernandez-Herrero, G. Laible, M. Dull, and R. Grosschedl. 1997. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature. 385:269–272.[CrossRef][Medline]
65 Scheuermann, R.H., and W.T. Garrard. 1999. MARs of antigen receptor and co-receptor genes. Crit. Rev. Eukaryot. Gene Expr. 9:295–310.[Medline]
66 Sakai, E., A. Bottaro, L. Davidson, B.P. Sleckman, and F.W. Alt. 1999. Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions. Proc. Natl. Acad. Sci. USA. 96:1526–1531.
67 Yi, M., P. Wu, K.W. Trevorrow, L. Claflin, and W.T. Garrard. 1999. Evidence that the Igkappa gene MAR regulates the probability of premature V-J joining and somatic hypermutation. J. Immunol. 162:6029–6039.
68 Hale, M.A., and W.T. Garrard. 1998. A targeted kappa immunoglobulin gene containing a deletion of the nuclear matrix association region exhibits spontaneous hyper-recombination in pre-B cells. Mol. Immunol. 35:609–620.[CrossRef][Medline]
69 Scheuermann, R.H., and U. Chen. 1989. A developmental-specific factor binds to suppressor sites flanking the immunoglobulin heavy-chain enhancer. Genes Dev. 3:1255–1266.
70 Kosak, S.T., J.A. Skok, K.L. Medina, R. Riblet, M.M. Le Beau, A.G. Fisher, and H. Singh. 2002. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science. 296:158–162.
71 Fuxa, M., J. Skok, A. Souabni, G. Salvagiotto, E. Roldan, and M. Busslinger. 2004. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18:411–422.
72 Roldan, E., M. Fuxa, W. Chong, D. Martinez, M. Novatchkova, M. Busslinger, and J.A. Skok. 2005. Locus ‘decontraction’ and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat. Immunol. 6:31–41.[CrossRef][Medline]
73 Sayegh, C., S. Jhunjhunwala, R. Riblet, and C. Murre. 2005. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. Genes Dev. 19:322–327.
74 Liu, Z., and W.T. Garrard. 2005. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases. Mol. Cell. Biol. 25:3220–3231.
75 Gu, H., J.D. Marth, P.C. Orban, H. Mossmann, and K. Rajewsky. 1994. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 265:103–106.
76 Kim, J.S., and C. Jobin. 2005. The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology. 115:375–387.[CrossRef][Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
